We don’t have a definitive cure largely because we still don’t know its exact cause. Read more at straitstimes.com.

Boehringer Ingelheim announced that its schizophrenia drug, iclepertin, did not achieve statistically significant ...

This is just a sampling of medical advancements in 2024 chosen for their common presence in the American population. It is ...

Psychiatric disorders often overlap and can make diagnosis difficult. Depression and anxiety, for example, can coexist and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

This new finding could help explain why some children develop neurodevelopmental disorders, such as autism or schizophrenia.

Schizophrenia is one of the 15 leading causes of disability worldwide. Roughly half of all patients exhibit co-occurring mental and/or behavioural health disorders. The serious mental health ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Psychiatric disorders often overlap and can make diagnosis difficult. Depression and anxiety, for example, can coexist and share symptoms. Schizophrenia and anorexia nervosa. Autism and attention ...